Skip to Content

Fidelity Healthy Future FAPHX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 12.64  /  +0.32 %
  • Total Assets 9.4 Mil
  • Adj. Expense Ratio
    1.050%
  • Expense Ratio 1.050%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.07%
  • Turnover 68%

USD | NAV as of May 22, 2024 | 1-Day Return as of May 22, 2024, 4:41 AM GMT+0

Morningstar’s Analysis FAPHX

Will FAPHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Fidelity Healthy Future’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FAPHX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 44.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

NVIDIA Corp

10.22 983,977
Technology

Procter & Gamble Co

6.75 650,460
Consumer Defensive

Nestle SA

4.97 478,444
Consumer Defensive

Thermo Fisher Scientific Inc

4.48 431,839
Healthcare

Vertex Pharmaceuticals Inc

3.49 336,498
Healthcare

Regeneron Pharmaceuticals Inc

3.47 333,984
Healthcare

UnitedHealth Group Inc

3.23 311,166
Healthcare

Uber Technologies Inc

2.78 267,463
Technology

L'Oreal SA

2.73 262,832
Consumer Defensive

Tesla Inc

2.29 220,968
Consumer Cyclical